ALISON GILLIS: Open Payments
NPI 1215790209 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$945 in 43 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $931 · 2025 $945
Food & beverage: $945
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $283 |
| United Therapeutics Corporation | 4 | $97 |
| Grifols USA, LLC | 3 | $95 |
| GlaxoSmithKline, LLC. | 4 | $68 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| PFIZER INC. | 2 | $44 |
| HARMONY BIOSCIENCES LLC | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| GENZYME CORPORATION | 2 | $34 |
Products named: TEZSPIRE, Prolastin-C Liquid, DUPIXENT, BREZTRI, FASENRA, NUCALA, Tyvaso, PREVNAR 20.
Industry payments across IA — which companies pay providers there.
